StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.70−0.17 (-8.85%)

Close on Nov 18, 2026Market cap $30.81MP/E –Yield –

Alterity Therapeutics net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2023 it was A$13.81M, up 7.5% from the year before. The highest annual figure on record is A$15.31M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2023Jun 30, 2023A$13.81M+7.5%
FY2022Jun 30, 2022A$12.85M-16.1%
FY2021Jun 30, 2021A$15.31M+13.8%
FY2020Jun 30, 2020A$13.46M+9.1%
FY2019Jun 30, 2019A$12.34M–

More Alterity Therapeutics figures

See a number that looks wrong?